Advertisement

Descemet stripping only in Fuchs’ endothelial dystrophy without use of topical Rho-kinase inhibitors: 5-year follow-up

      Abstract

      Objective

      To describe 5-year postoperative outcomes of a small series of Fuchs’ endothelial dystrophy (FED) patients who underwent Descemet stripping only (DSO) with a scraping technique.

      Methods

      DSO technique and early clinical outcomes of 5 patients with mild central FED were previously reported. In the same cohort of patients, corrected distance visual acuity, central corneal ultrasound pachymetry, refractive spherical equivalent, endothelial cell count, slit-lamp photography, and corneal Scheimpflug tomography were obtained at baseline, 6 months, and 1 and 5 years postoperatively. No patient used topical Rho-kinase inhibitors at any point in time.

      Results

      One patient (20%) failed to clear the early postoperative edema and 1 patient (20%) developed corneal decompensation 1 year after DSO. Both patients underwent successful Descemet stripping automated endothelial keratoplasty. The remaining 3 patients had stable corrected distance visual acuity, progressive reduction of corneal ultrasound pachymetry, and mild myopic shift of the refractive spherical equivalent over the follow-up time. An improvement in posterior stromal opacities and irregular astigmatism was observed, whereas posterior elevation at Scheimpflug tomography remained unchanged.

      Conclusion

      At 5 years postoperatively, DSO with a scraping technique and without Rho-kinase inhibitors resulted in sustained clinical amelioration of 3 of 5 patients (60%) with mild FED.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kaufman AR
        • Nosé RM
        • Pineda R.
        Descemetorhexis without endothelial keratoplasty (DWEK): proposal for nomenclature standardization.
        Cornea. 2018; 37: e20-e21
        • Moloney G
        • Iovieno A
        • Colby KA
        Reply.
        Cornea. 2018; 37: e21-e22
        • Iovieno A
        • Neri A
        • Soldani AM
        • Adani C
        • Fontana L.
        Descemetorhexis without graft placement for the treatment of Fuchs’ endothelial dystrophy: preliminary results and review of the literature.
        Cornea. 2017; 36: 637-641
        • Borkar DS
        • Veldman P
        • Colby KA.
        Treatment of Fuchs’ endothelial dystrophy by Descemet stripping without endothelial keratoplasty.
        Cornea. 2016; 35: 1267-1273
        • Moloney G
        • Petsoglou C
        • Ball M
        • et al.
        Descemetorhexis without grafting for Fuchs’ endothelial dystrophy: supplementation with topical ripasudil.
        Cornea. 2017; 36: 642-648
        • Moloney G
        • Chan UT
        • Hamilton A
        • Zahidin AM
        • Grigg JR
        • Devasahayam RN.
        Descemetorhexis for Fuchs’ dystrophy.
        Can J Ophthalmol. 2015; 50: 68-72
        • Moloney G
        • Garcerant Congote D
        • Hirnschall N
        • et al.
        Descemet stripping only supplemented with topical ripasudil for Fuchs’ endothelial dystrophy :12-month outcomes of the Sydney Eye Hospital study.
        Cornea. 2021; 40: 320-326
        • Macsai MS
        • Shiloach M.
        Use of topical Rho kinase inhibitors in the treatment of Fuchs’ dystrophy after Descemet stripping only.
        Cornea. 2019; 38: 529-534
        • Huang MJ
        • Kane S
        • Dhaliwal DK.
        Descemetorhexis without endothelial keratoplasty versus DMEK for treatment of Fuchs’ endothelial corneal dystrophy.
        Cornea. 2018; 37: 1479-1483
        • Artaechevarria Artieda J
        • Wells M
        • Devasahayam RN
        • Moloney G
        5-Year outcomes of Descemet stripping only in Fuchs’ dystrophy.
        Cornea. 2020; 39: 1048-1051
        • Rao R
        • Borkar DS
        • Colby KA
        • Veldman PB.
        Descemet membrane endothelial keratoplasty after failed Descemet stripping without endothelial keratoplasty.
        Cornea. 2017; 36: 763-766
        • Birbal RS
        • Parker J
        • Dirisamer M
        • et al.
        Descemet membrane endothelial transfer: ultimate outcome.
        Cornea. 2018; 37: 141-144
        • Kinoshita S
        • Colby KA
        • Kruse FE
        A close look at the clinical efficacy of Rho-associated kinase inhibitor eye drops for Fuchs’ endothelial corneal dystrophy.
        Cornea. 2021; : 1-4
        • Okumura N
        • Okazaki Y
        • Inoue R
        • et al.
        Rho-associated kinase inhibitor eye drop (ripasudil) transiently alters the morphology of corneal endothelial cells.
        Invest Ophthalmol Vis Sci. 2015; 56: 7560-7567
        • Okumura N
        • Okazaki Y
        • Inoue R
        • et al.
        Effect of the rho-associated kinase inhibitor eye drop (ripasudil) on corneal endothelial wound healing.
        Invest Ophthalmol Vis Sci. 2016; 57: 1284-1292
        • Schlötzer-Schrehardt U
        • Zenkel M
        • Strunz M
        • et al.
        Potential functional restoration of corneal endothelial cells in Fuchs’ endothelial corneal dystrophy by ROCK inhibitor (ripasudil).
        Am J Ophthalmol. 2021; 224: 185-199
        • Okumura N
        • Kinoshita S
        • Koizumi N.
        Application of Rho kinase inhibitors for the treatment of corneal endothelial diseases.
        J Ophthalmol. 2017; 20172646904
        • Kinoshita S
        • Koizumi N
        • Ueno M
        • et al.
        Injection of cultured cells with a ROCK inhibitor for bullous keratopathy.
        N Engl J Med. 2018; 378: 995-1003
        • Koizumi N
        • Okumura N
        • Ueno M
        • Nakagawa H
        • Hamuro J
        • Kinoshita S.
        Rho-associated kinase inhibitor eye drop treatment as a possible medical treatment for Fuchs’ corneal dystrophy.
        Cornea. 2013; 32: 1167-1170
        • Ploysangam P
        • Patel SP.
        A case report illustrating the postoperative course of descemetorhexis without endothelial keratoplasty with topical netarsudil therapy.
        Case Rep Ophthalmol Med. 2019; 2019: 1-7
        • Garcerant D
        • Hirnschall N
        • Toalster N
        • Zhu M
        • Wen L
        • Moloney G.
        Descemet's stripping without endothelial keratoplasty.
        Curr Opin Ophthalmol. 2019; 30: 275-285
        • Davies E
        • Jurkunas U
        • Pineda R.
        Predictive factors for corneal clearance after descemetorhexis without endothelial keratoplasty.
        Cornea. 2018; 37: 137-140
        • Kassumeh S
        • von Studnitz A
        • Priglinger SG
        • et al.
        Ex vivo excimer laser ablation of cornea guttata and ROCK inhibitor-aided endothelial recolonization of ablated central cornea.
        Acta Ophthalmol. 2020; 98: e773-e780
        • Pilger D
        • von Sonnleithner C
        • Bertelmann E
        • Maier A-KB
        • Joussen AM
        • Torun N.
        Exploring the precision of femtosecond laser-assisted descemetorhexis in Descemet membrane endothelial keratoplasty.
        BMJ Open Ophthalmol. 2018; 3e000148
        • Miyata K
        • Kamiya K
        • Takahashi T
        • et al.
        Time course of changes in corneal forward shift after excimer laser photorefractive keratectomy.
        Arch Ophthalmol. 2002; 120: 896-900
        • Amigó A
        • Martinez-Sorribes P
        • Recuerda M.
        Refractive changes induced by spherical aberration in laser correction procedures: an adaptive optics study.
        J Refract Surg. 2017; 33: 470-474